Lung Disease News and Research

RSS

Novel peptide suppresses the damaging lung inflammation seen in ARDS

A novel peptide designed by University of California, Irvine researchers has been found to suppress the damaging lung inflammation seen in acute respiratory distress syndrome, or ARDS.

17 Jan 2023

New community diagnostic center set to benefit thousands of patients in Stockton-on-Tees

Thousands of patients in Stockton-on-Tees are set to benefit from quicker access to tests, checks and scans - with a new community diagnostic center set to open later this year.

16 Jan 2023

The role of omega-3 and omega-6 metabolites during pregnancy

Omega-3 and -6 fatty acids ingested through the diet are metabolized into bioactive compounds that influence inflammation. In a recent the journal Biomedicines study, scientists reviewed the existing literature and summarized their findings related to the role of omega-3 and omega-6 metabolites during pregnancy.

15 Jan 2023

Deep divers make adaptations to make their hearts, lungs work effectively in low oxygen conditions

Scientists detected deep divers make adaptations that make their hearts and lungs work more effectively in low oxygen conditions.

11 Jan 2023

Keeping hydrated can reduce aging and extend disease-free life

In a recent study published in the journal eBioMedicine, researchers assessed the association between hydration and aging.

3 Jan 2023

Why do some people develop persistent lung sequelae after severe COVID-19?

Clinical presentation following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from mild self-limiting illness to severe respiratory failure. Many studies have analyzed the early acute phases of coronavirus disease 2019(COVID-19), but few focused on the longer-term sequelae following infection.

2 Jan 2023

Good hydration may slow down aging and prolong disease-free life

Adults who stay well-hydrated appear to be healthier, develop fewer chronic conditions, such as heart and lung disease, and live longer than those who may not get sufficient fluids, according to a National Institutes of Health study published in eBioMedicine.

2 Jan 2023

Using the gut microbiome to understand and treat respiratory diseases

Researchers review the role of the gut microbiome in certain respiratory diseases.

22 Dec 2022

Adults could achieve physical activity targets by walking “Teabag style” for a few minutes each day

Adults could achieve global physical activity targets by walking inefficiently for just a few minutes each day, finds a study in the Christmas issue of The BMJ.

22 Dec 2022

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Researchers observe that COVID-19 patients were at an increased risk of developing certain conditions.

21 Dec 2022

Comprehensive lung cell atlas offers insights into an unexpected immune niche in the airways

The most comprehensive lung cell atlas to date, from the Wellcome Sanger Institute and collaborators, has revealed 11 new lung cell types and offers detailed insight into an immune process involved in fighting lung infections.

21 Dec 2022

The debilitating effects of long-COVID in the U.S.

A new study posted to the preprint server medRxiv* discusses chronic disability due to long COVID in the United States.

14 Dec 2022

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

Researchers compared the efficiency of bioengineered soluble ACE-2 concerning brain protection during COVID-19.

12 Dec 2022

New spatial cell atlas of the developing human lung identifies 144 cell states

The developing human lung has been mapped in unprecedented detail, identifying 144 cell states in the early stages of life, and uncovering new links between developmental cells and lung cancer.

8 Dec 2022

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer, according to updated results from the DESTINY-Breast03 phase III clinical trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for patients with HER2-positive metastatic breast cancer previously treated with trastuzumab emtansine (T-DM1), according to results from the phase III DESTINY-Breast02 trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.

7 Dec 2022

Study assesses the prevalence of residual lung abnormalities following COVID-19 hospitalization

In a new study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine, researchers sought to determine the percentage of COVID-19 patients discharged from the hospital who had a type of fibrotic lung damage, known as interstitial lung disease, that requires ongoing follow-up care.

2 Dec 2022

Photon-counting CT may help to effectively identify post-COVID patients at risk for lung damage

New CT technology outperforms conventional CT in detecting subtle damage in the lungs of patients with persistent symptoms of COVID-19, according to a new study published in Radiology, a journal of the Radiological Society of North America.

29 Nov 2022

Lung Disease News and Research

Novel peptide suppresses the damaging lung inflammation seen in ARDS

New community diagnostic center set to benefit thousands of patients in Stockton-on-Tees

The role of omega-3 and omega-6 metabolites during pregnancy

Deep divers make adaptations to make their hearts, lungs work effectively in low oxygen conditions

Keeping hydrated can reduce aging and extend disease-free life

Why do some people develop persistent lung sequelae after severe COVID-19?

Good hydration may slow down aging and prolong disease-free life

Using the gut microbiome to understand and treat respiratory diseases

Adults could achieve physical activity targets by walking “Teabag style” for a few minutes each day

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

Comprehensive lung cell atlas offers insights into an unexpected immune niche in the airways

The debilitating effects of long-COVID in the U.S.

Bioengineered soluble ACE2 for brain protection against SARS-CoV-2 infection

New spatial cell atlas of the developing human lung identifies 144 cell states

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Study assesses the prevalence of residual lung abnormalities following COVID-19 hospitalization

Photon-counting CT may help to effectively identify post-COVID patients at risk for lung damage

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News